Trial intelligence / Profile preview

PET-MR D2 Receptor Imaging in Prolactinoma

NCT03717454Unknown

Start
Dec 2018
Primary completion
Dec 2021
01

Overview

Open-label trial (2 arms). Primary endpoint: Change from baseline on PRL level at 6 months. Status: unknown.

Beyond the preview

Go deeper on NCT03717454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03717454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call